FOXO1 and breast carcinoma: QKI may cause dysgenesis of FoxO1 through post-transcriptional inhibition, and lead to the occurrence and progression of breast cancer, which is characterized by that QKI can directly bind to the 3’UTR of FoxO1 and reduce its mRNA stability, this effect is critical for breast cancer occurrence and progression (13).